apalutamide
Showing 26 - 50 of 62
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, PSA Progression Trial in San Francisco (Apalutamide,
Recruiting
- Castration Levels of Testosterone
- +3 more
- Apalutamide
- Stereotactic Body Radiation Therapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 26, 2021
Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)
Recruiting
- Prostate Cancer
- Apalutamide
- Enzalutamide
-
Shatin, Hong KongPrince of Wales Hospital
Aug 3, 2021
Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in
Completed
- Stage III Prostate Adenocarcinoma AJCC v7
- +3 more
- Abiraterone Acetate
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 15, 2021
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Prostatic Tumors Trial in China (Apalutamide, Placebo, Androgen-deprivation Therapy (ADT))
Recruiting
- Prostatic Neoplasms
- Apalutamide
- +2 more
-
Beijing, China
- +29 more
Aug 15, 2022
Metastatic Hormone Sensitive Prostate Cancer Treated With
Not yet recruiting
- Metastatic Hormone-sensitive Prostate Cancer
- Apalutamide
- Enzalutamide
-
Innsbruck, Austria
- +42 more
Jun 5, 2023
Prostate Cancer Trial in La Jolla, Boston, New York (Apalutamide, Leuprolide, Prednisone)
Active, not recruiting
- Prostate Cancer
- Apalutamide
- +3 more
-
La Jolla, California
- +3 more
Sep 1, 2021
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Prostate Cancer Trial in Brazil (Apalutamide, Abiraterone, ADT)
Completed
- Prostate Cancer
- Apalutamide
- +3 more
-
Salvador, Bahia, Brazil
- +13 more
Jul 5, 2021
Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)
Unknown status
- Prostate Cancer
- Goserelin
- +3 more
-
Sao Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
May 14, 2021
Cancer of Prostate Trial in Belgium (Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin
Recruiting
- Cancer of Prostate
- Apalutamide
- +4 more
-
Aalst, Belgium
- +8 more
Aug 4, 2021
Prostate Cancer Trial in France (Apalutamide, Salvage radiotherapy (SRT), Luteinising Hormone Releasing Hormone agonist (LHRHa))
Recruiting
- Prostate Cancer
- Apalutamide
- +2 more
-
Albi, France
- +14 more
Sep 22, 2021
Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,
Recruiting
- Neoadjuvant Therapy
- +3 more
- ADT
- +8 more
-
Nanjing, Jiangsu, ChinaDepartment of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Houston, Texas
- +2 more
Feb 11, 2022
Metastatic Castration-sensitive Prostate Cancer Trial in Osaka-sayama (Apalutamide)
Recruiting
- Metastatic Castration-sensitive Prostate Cancer
- Apalutamide
-
Ōsaka-sayama, Osaka, JapanKindai University Hospital
Dec 6, 2020
Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)
Withdrawn
- Prostatic Neoplasms, Castration-Resistant
- Abiraterone
- Apalutamide
- (no location specified)
Nov 15, 2020
Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)
Recruiting
- Advanced Cancer
- Solid Tumor
- Alectinib
- +13 more
-
Helsinki, Uusimaa, Finland
- +2 more
Jun 8, 2022
Newly Diagnosed Oligometastatic Prostate Cancer Trial in Long Beach, West Los Angeles, Richmond (procedure, radiation, drug)
Active, not recruiting
- Newly Diagnosed Oligometastatic Prostate Cancer
- radical prostatectomy
- +4 more
-
Long Beach, California
- +2 more
Mar 16, 2022
Prostate Cancer Trial in New York (apalutamide, Everolimus)
Completed
- Prostate Cancer
- apalutamide
- Everolimus
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 29, 2021
Prostate Cancer Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Prostate Cancer
- Leuprolide acetate
- +9 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2022
Prostate Cancer Trial (Radiation Therapy, Apalutamide, Luteinising Hormone Releasing Hormone analog agonist (LHRHa))
Withdrawn
- Prostate Cancer
- Radiation Therapy
- +3 more
- (no location specified)
Aug 13, 2020
Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))
Active, not recruiting
- Prostate Cancer
- Apalutamide
- +2 more
-
Homewood, Alabama
- +228 more
Aug 2, 2022
Healthy Trial in Merksem (Apalutamide)
Completed
- Healthy
- Apalutamide
-
Merksem, BelgiumClinical Pharmacology Unit
Aug 7, 2020
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,
Recruiting
- Prostate Carcinoma
- +6 more
- Abiraterone Acetate
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
- +3 more
-
Phoenix, Arizona
- +183 more
Jan 17, 2023